Trial Profile
Phase II Study of Rituximab Combined With ESHAP in Patients With Relapse or Refractory DLBCL.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2012
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cisplatin; Cytarabine; Etoposide; Methylprednisolone
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- Acronyms ESHAP-DLBCL
- 18 Jan 2011 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 25 Dec 2007 New trial record.